Log in to save to my catalogue

CYP2D6 pharmacogenomics

CYP2D6 pharmacogenomics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5534b1448bb84925832ca3cb589d96df

CYP2D6 pharmacogenomics

About this item

Full title

CYP2D6 pharmacogenomics

Publisher

Cairo, Egypt: Elsevier B.V

Journal title

The Egyptian journal of medical human genetics, 2017-10, Vol.18 (4), p.309-313

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Elsevier B.V

More information

Scope and Contents

Contents

Cytochromes are proteins that catalyze electron transfer reactions of many metabolic pathways. They are involved in drug metabolism and thus determines the therapeutic safety and efficacy of drugs in patients. Cytochrome P450 in mitochondria accounts for 90% of the oxidative metabolism of clinically used drugs during phase 1 reaction. CYP2D6 is a m...

Alternative Titles

Full title

CYP2D6 pharmacogenomics

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5534b1448bb84925832ca3cb589d96df

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5534b1448bb84925832ca3cb589d96df

Other Identifiers

ISSN

1110-8630

E-ISSN

2090-2441

DOI

10.1016/j.ejmhg.2017.03.001

How to access this item